{"id":"https://openalex.org/W2071723486","doi":"https://doi.org/10.1176/ajp.156.10.1646","title":"Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia","display_name":"Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia","publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W2071723486","doi":"https://doi.org/10.1176/ajp.156.10.1646","mag":"2071723486","pmid":"https://pubmed.ncbi.nlm.nih.gov/10518181"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.156.10.1646","doi":"https://doi.org/10.1176/ajp.156.10.1646","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.156.10.1646","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056032971","display_name":"Caleb M. Adler","orcid":"https://orcid.org/0000-0003-2889-7764","observed_orcids":["https://orcid.org/0000-0003-2889-7764"]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caleb M. Adler","raw_affiliation_strings":["Experimental Therapeutics Branch, NIMH, Bethesda, Md., USA. cal.adler@psychiatry.uc.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Therapeutics Branch, NIMH, Bethesda, Md., USA. cal.adler@psychiatry.uc.edu","institution_ids":["https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112015334","display_name":"Anil K. Malhotra","orcid":"https://orcid.org/0000-0001-9664-4182","observed_orcids":["https://orcid.org/0000-0001-9664-4182"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil K. Malhotra","raw_affiliation_strings":["","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067068796","display_name":"Igor Elman","orcid":"https://orcid.org/0000-0002-1345-2677","observed_orcids":["https://orcid.org/0000-0002-1345-2677"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Igor Elman","raw_affiliation_strings":["","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068879555","display_name":"Terry E. Goldberg","orcid":"https://orcid.org/0000-0002-2455-7247","observed_orcids":["https://orcid.org/0000-0002-2455-7247"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Terry Goldberg","raw_affiliation_strings":["","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108779038","display_name":"Michael F. Egan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Egan","raw_affiliation_strings":["","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113554926","display_name":"David Pickar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Pickar","raw_affiliation_strings":["","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110607987","display_name":"Alan F. Breier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Breier","raw_affiliation_strings":["","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.5314,"has_fulltext":false,"cited_by_count":342,"citation_normalized_percentile":{"value":0.92483564,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"156","issue":"10","first_page":"1646","last_page":"1649"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/thought-disorder","display_name":"thought disorder","score":0.9750000238418579},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9649999737739563},{"id":"https://openalex.org/keywords/nmda-receptor-antagonism","display_name":"NMDA receptor antagonism","score":0.871999979019165},{"id":"https://openalex.org/keywords/subanesthetic-ketamine","display_name":"subanesthetic ketamine","score":0.734000027179718},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5640000104904175},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.863791823387146},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.8562137484550476},{"id":"https://openalex.org/C2776313836","wikidata":"https://www.wikidata.org/wiki/Q1188698","display_name":"Thought disorder","level":3,"score":0.756139874458313},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6573311686515808},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5947921872138977},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.45846283435821533},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4238799810409546},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4193562865257263},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.3795301914215088},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.3289461135864258},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2785189151763916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2707676887512207},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15853071212768555}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003937","descriptor_name":"Diagnosis, Differential","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1176/ajp.156.10.1646","doi":"https://doi.org/10.1176/ajp.156.10.1646","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.156.10.1646","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:10518181","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10518181","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1967089450","https://openalex.org/W1985807703","https://openalex.org/W1986661341","https://openalex.org/W1992931876","https://openalex.org/W1996983763","https://openalex.org/W2005185608","https://openalex.org/W2009134635","https://openalex.org/W2015723037","https://openalex.org/W2020844317","https://openalex.org/W2026738643","https://openalex.org/W2028884770","https://openalex.org/W2032187584","https://openalex.org/W2047173553","https://openalex.org/W2060196675","https://openalex.org/W2060298350","https://openalex.org/W2061084307","https://openalex.org/W2063571142","https://openalex.org/W2069309986","https://openalex.org/W2077609442","https://openalex.org/W2079033779","https://openalex.org/W2119779293","https://openalex.org/W2138368199","https://openalex.org/W2154497083","https://openalex.org/W2160286576","https://openalex.org/W2253549383","https://openalex.org/W2307930405"],"related_works":["https://openalex.org/W1977608731","https://openalex.org/W1985807703","https://openalex.org/W1979757803","https://openalex.org/W1981296401","https://openalex.org/W2119779293","https://openalex.org/W2018486568","https://openalex.org/W2032187584","https://openalex.org/W2525947448","https://openalex.org/W2176587016","https://openalex.org/W2144798911"],"abstract_inverted_index":{"OBJECTIVE:":[0],"This":[1],"study":[2],"sought":[3],"to":[4,43,133],"determine":[5],"whether":[6],"thought":[7,23,45,125,135],"disorder":[8,24,46,126,136],"induced":[9],"in":[10,26,47,60,113,127,137,151],"healthy":[11,48,96,128],"volunteers":[12,49,97,129],"by":[13],"the":[14,22,34,81,84,107,117,134,145,148],"N-methyl-D-aspartic":[15],"acid":[16],"(NMDA)":[17],"receptor":[18,150],"antagonist":[19],"ketamine":[20,58,99],"resembles":[21],"found":[25],"patients":[27,92,138],"with":[28,67,93,139],"schizophrenia.":[29,156],"METHOD:":[30],"The":[31],"Scale":[32,82],"for":[33,83,91,144],"Assessment":[35,85],"of":[36,57,63,86,106,147,155],"Thought,":[37,87],"Language,":[38,88],"and":[39,59,89,95,141],"Communication":[40,90],"was":[41],"used":[42],"assess":[44],"(N":[50,69],"=":[51,70],"10)":[52],"who":[53,72],"received":[54],"subanesthetic":[55],"doses":[56],"a":[61,152],"group":[62],"clinically":[64],"stable":[65],"inpatients":[66],"schizophrenia":[68,94,140],"15)":[71],"did":[73,100],"not":[74,101,131],"receive":[75],"ketamine.":[76],"RESULTS:":[77],"Mean":[78],"scores":[79],"on":[80],"receiving":[98],"differ":[102],"significantly.":[103],"Moreover,":[104],"three":[105],"four":[108],"highest":[109],"rated":[110],"test":[111],"items":[112],"both":[114],"groups":[115],"were":[116],"same.":[118],"CONCLUSIONS:":[119],"These":[120],"data":[121],"suggest":[122],"that":[123],"ketamine-induced":[124],"is":[130],"dissimilar":[132],"provide":[142],"support":[143],"involvement":[146],"NMDA":[149],"cardinal":[153],"symptom":[154]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":24},{"year":2012,"cited_by_count":21}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}